Publikationen, an denen er mitarbeitet Marcos Antonio González López (2)

2023

  1. Reply to: “Comment on ‘Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes’”

    Journal of the American Academy of Dermatology

2019

  1. Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes

    Journal of the American Academy of Dermatology, Vol. 80, Núm. 5, pp. 1455-1457